Lauren Dembeck, PhD

Researchers sought to determine whether the incidence of CAT was different across designated racial groups.

Researchers sought to determine whether elevated CD24 expression on plasma cells was a prognostic factor in multiple myeloma.

A systematic review revealed substantial variations in the cost of surgery, chemotherapy, and radiotherapy for colorectal cancer.

Many patients with advanced ovarian cancer may be eligible for first-line maintenance with a PARP inhibitor, research suggests.

Researchers sought to determine whether the Khorana score would be able to risk-stratify patients according to the 6-month risk of incident VTE.

Patients with lung cancer who underwent COVID-19 vaccination while receiving immune checkpoint inhibitors did not have an increased risk of immune-related adverse events.

Researchers sought to determine whether elevated platelet-to-lymphocyte ratio and plasma C-reactive protein level would help predict prognosis for patients with MDS.

Researchers sought to determine whether patients were equally represented along designated racial groups in FDA drug trails for multiple myeloma.

Researchers sought to determine whether liso-cel would have acceptable toxicity and effectiveness in patients with SLL or CLL.

Researchers sought to determine the effect of transplant-related complications and socioeconomic factors on revaccination schedule adherence among pediatric patients following allo-HSCT.